» Articles » PMID: 1118019

Membrane Protein Kinase Alteration in Duchenne Muscular Dystrophy

Overview
Journal Nature
Specialty Science
Date 1975 Mar 27
PMID 1118019
Citations 14
Authors
Affiliations
Soon will be listed here.
Citing Articles

Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.

Capogrosso R, Mantuano P, Uaesoontrachoon K, Cozzoli A, Giustino A, Dow T FASEB J. 2017; 32(2):1025-1043.

PMID: 29097503 PMC: 5888399. DOI: 10.1096/fj.201700182RRR.


Elusive sources of variability of dystrophin rescue by exon skipping.

Vila M, Benny Klimek M, Novak J, Rayavarapu S, Uaesoontrachoon K, Boehler J Skelet Muscle. 2015; 5:44.

PMID: 26634117 PMC: 4667482. DOI: 10.1186/s13395-015-0070-6.


Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.

Uaesoontrachoon K, Quinn J, Tatem K, Van der Meulen J, Yu Q, Phadke A Hum Mol Genet. 2014; 23(12):3239-49.

PMID: 24463621 PMC: 4030778. DOI: 10.1093/hmg/ddu033.


Measurement of erythrocyte membrane elasticity as a diagnostic aid in Duchenne muscular dystrophy.

Nash G, WYARD S J Med Genet. 1982; 19(4):262-5.

PMID: 7120313 PMC: 1048890. DOI: 10.1136/jmg.19.4.262.


High resolution two-dimensional gel electrophoresis of human erythrocyte membrane proteins.

Copeland B, Todd S, Furlong C Am J Hum Genet. 1982; 34(1):15-31.

PMID: 7081216 PMC: 1685218.